Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
Pricing and availability of generic Indian Ledipasvir and Sofosbuvir co-formulation as on 26 April 2016
Pricing and availability of generic Indian Ledipasvir and Sofosbuvir co-formulation as on 26 April 2016
Download PDF
May 3, 2016
/
News
Share
the Post
Related
Posts
Part 1: What is hepatitis C and how is it diagnosed?
Strategies to Secure Access to Generic HCV Medicines
Glecaprevir-Pibrentasvir Effective for Hepatitis C After Treatment Failure
APN+ joins MTAAG in congratulating Malaysia on sofosbuvir compulsory license
2018 IAS Brief Document Ending an Epidemic – Prioritizing People Who Inject Drugs in HCV elimination Efforts.
Hepatitis C Treatment Snapshots: ledipasvir and sofosbuvir co-formulation
Updated WHO screening, care and treatment of persons with hepatitis C infection_ April 2016.
Response from CEO, CHAI about the Quick Start program in November 2016
